MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes ; volume:90 ; number:12 ; day:3 ; month:2 ; year:2016 ; pages:3087-3098 ; date:12.2016
Archives of toxicology ; 90, Heft 12 (3.2.2016), 3087-3098, 12.2016
- Creator
-
Chaudhari, Umesh
- Contributor
-
Nemade, Harshal
Gaspar, John Antonydas
Hescheler, Jürgen
Hengstler, Jan G.
Sachinidis, Agapios
SpringerLink (Online service)
- DOI
-
10.1007/s00204-016-1668-0
- URN
-
urn:nbn:de:1111-2016120311542
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chaudhari, Umesh
- Nemade, Harshal
- Gaspar, John Antonydas
- Hescheler, Jürgen
- Hengstler, Jan G.
- Sachinidis, Agapios
- SpringerLink (Online service)
Other Objects (12)
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Toxikologie - Wurzeln und Wandel
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Toxikologie - Wurzeln und Wandel
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy